Table 2 lncRNA-MEG3, miR125a-5P, CXCL13 and NF-kB levels in patients with ITP.
Variable | blncRNA-MEG3 | cmiR125a-5P | dCXCL13 | eNF-kB (pg/mL) |
|---|---|---|---|---|
Site of bleeding | ||||
Skin | 5.41 ± 1.94 | 0.72 ± 0.20 | 100.8 ± 24.56 | 172.52 ± 40.09 |
Mucosal | 7.22 ± 1.91 | 0.53 ± 0.19 | 122.4 ± 28.31 | 202.09 ± 37.33 |
Organ | 7.10 ± 1.69 | 0.6 ± 0.2 | 111.7 ± 22.04 | 194.13 ± 35.77 |
aP value | 0.024 | 0.026 | 0.034 | 0.26 |
Platelet transfusion | ||||
Yes | 7.27 ± 1.85 | 0.53 ± 0.18 | 121.24 ± 25.63 | 202.74 ± 37.14 |
No | 5.91 ± 1.95 | 0.68 ± 0.21 | 104.31 ± 27.3 | 177.46 ± 36.93 |
aP value | 0.033 | 0.033 | 0.023 | 0.045 |
Steroid response | ||||
Yes | 5.35 ± 1.28 | 0.69 ± 0.15 | 98.94 ± 16.36 | 170.24 ± 28.55 |
No | 7.66 ± 1.81 | 0.52 ± 0.21 | 125.11 ± 27.89 | 208.03 ± 37.28 |
aP value | <0.001 | 0.016 | 0.005 | 0.002 |
Need for Rituximab | ||||
Yes | 7.53 ± 1.54 | 0.55 ± 0.19 | 123.36 ± 24.82 | 204.85 ± 33.5 |
No | 6.55 ± 2.06 | 0.60 ± 0.21 | 112.59 ± 27.74 | 190.16 ± 39.95 |
aP value | 0.062 | 0.725 | 0.327 | 0.314 |
Need for splenectomy | ||||
Yes | 7.96 ± 1.93 | 0.53 ± 0.22 | 123 ± 31.65 | 213.67 ± 43.68 |
No | 6.61 ± 1.94 | 0.6 ± 0.2 | 114.03 ± 26.7 | 190.69 ± 37.48 |
aP value | 0.049 | 0.442 | 0.637 | 0.286 |
